Evidence map›Paper›PMID 27619682›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Determination of a CD4

Morteza Jafarinia, Fereshteh Mehdipour, Seyed Vahid Hosseini, Leila Ghahramani, Masood Hosseinzadeh, Abbas Ghaderi

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Morteza JafariniaShiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, P.O. Box: 71345-1798, Shiraz, Iran.
Fereshteh MehdipourShiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, P.O. Box: 71345-1798, Shiraz, Iran.
Seyed Vahid HosseiniColorectal Research Center, Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Leila GhahramaniColorectal Research Center, Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Masood HosseinzadehDepartment of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Abbas GhaderiShiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, P.O. Box: 71345-1798, Shiraz, Iran. ghaderia@sums.ac.ir.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD4

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overCD4-Positive T-LymphocytesColorectal NeoplasmsFemaleFlow CytometryForkhead Transcription FactorsHumansInterferon-gammaInterleukin-2 Receptor alpha SubunitLymph NodesLymphocytes, Tumor-InfiltratingMaleMiddle AgedForkhead Transcription FactorsFOXP3 protein, humanInterferon-gammaInterleukin-2 Receptor alpha SubunitCD4+CD25−FoxP3+ cellsColorectal cancerCytokineLymph node

Identifiers

PMID27619682
OpenAlexW2518745757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.